April 13, 2021 MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson’s Disease and Expands Pipeline to Aging
April 13, 2021 MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson’s Disease and Expands Pipeline to Aging
November 17, 2020 MedRhythms, Roux Institute Partner in the Fields of Neuroscience, Artificial Intelligence
November 17, 2020 MedRhythms, Roux Institute Partner in the Fields of Neuroscience, Artificial Intelligence
June 15, 2020 MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic
June 15, 2020 MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic
April 17, 2020 MedRhythms Announces an Expansion of Intellectual Property Portfolio, Securing Patent on Audio Engine for Digital Therapeutics Platform
April 17, 2020 MedRhythms Announces an Expansion of Intellectual Property Portfolio, Securing Patent on Audio Engine for Digital Therapeutics Platform
February 12, 2020 MedRhythms CEO Speaking at American Physical Therapy Association Combined Sections Meeting; Feasibility Study Results to be Presented
February 12, 2020 MedRhythms CEO Speaking at American Physical Therapy Association Combined Sections Meeting; Feasibility Study Results to be Presented
January 14, 2020 MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson’s Disease
January 14, 2020 MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson’s Disease
December 16, 2019 MedRhythms Announces Partnership with Gait Up, Leader in Inertial Sensor Development
December 16, 2019 MedRhythms Announces Partnership with Gait Up, Leader in Inertial Sensor Development
December 2, 2019 MedRhythms Announces Issuance of US Patent Covering Their Innovative Digital Therapeutic Platform
December 2, 2019 MedRhythms Announces Issuance of US Patent Covering Their Innovative Digital Therapeutic Platform